Evidence map›Paper›PMID 29776414›Full record

ArticleBMC complementary and alternative medicine2018

GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.

Gulzar Ahmad Bhat, Haseeb A Khan, Abdullah S Alhomida, Poonam Sharma, Rambir Singh, Bilal Ahmad Paray

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07240246 (Effect of a Dietary Supplement), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07240246 nacompletednot on this mapstarted 2025, after this paper: background citation

Effect of a Dietary Supplement (FitLine TopShape) on the Incretin Response

TypeinterventionalSponsorFFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & InnovationRan2025 to 2026Enrolled40ConditionsGLP-1, Obesity &Amp, Overweight, Dietary SupplementArmsIntervention: Dietary Supplement with Plant Extracts, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Evaluation of the impact ofHistology and histopathology · 2025
    Article
  3. Role of Fenugreek, Cinnamon,Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Boosting GLP-1 by Natural Products.Advances in experimental medicine and biology · 2021
    Article
  7. The Effect ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  8. Article
  9. Methanol leaf extract ofVeterinary world · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Antidiabetic Activity ofAvicenna journal of medical biotechnology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Gulzar Ahmad BhatDepartment of Zoology, HNB Central University Garhwal, Srinagar, Uttarakhand, 249161, India.
Haseeb A KhanDepartment of Biochemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia. haseeb@ksu.edu.sa.
Abdullah S AlhomidaDepartment of Biochemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Poonam SharmaDepartment of Zoology, Indira Gandhi National Tribal University, (A Central University), Amarkantak, M.P, 484887, India.
Rambir SinghDepartment of Biomedical Sciences, Bundelkhand University, Jhansi, India.
Bilal Ahmad ParayZoology Department, College of Science, King Saud University, PO Box 2455, Riyadh, 11451, Saudi Arabia.
King Saud University · SABundelkhand University · INHemwati Nandan Bahuguna Garhwal University · INIndira Gandhi National Tribal University · IN

Funding

The authors would like to express their sincere appreciation to the Deanship of Scientific Research at the King Saud University, Riyadh, Saudi Arabia for funding this Research Group project RGP-009.
6 · The paper itself

Abstract

backgroundDiabetes mellitus is one of the major global health disorders increasing at an alarming rate in both developed and developing countries. The objective of this study was to assess the effect of aqueous extract of Momordica charantia (AEMC) on fasting blood glucose (FBG), tissue glycogen, glycosylated haemoglobin, plasma concentrations of insulin and GLP-1 hormone (glucagon-like peptide 1) in healthy and diabetic wistar rats.

methodsMale Wistar rats (both normal and diabetic) were treated with AEMC by gavaging (300 mg/kg body wt/day for 28 days).

resultsAEMC was found to increase tissue glycogen, serum insulin and GLP-1 non-significantly (P > 0.05) in normal, significantly (P < 0.01) in diabetic Wistar rats, whereas decrease in FBG and Glycosylated haemoglobin non-significantly (P > 0.05) in normal, significantly (P < 0.01) in diabetic Wistar rats. The elevation of GLP-1 level in normal and diabetic treated groups may be due to the L-cell regeneration and proliferation by binding with L-cell receptors and makes a conformational change, resulting in the activation of a series of signal transducers. The polar molecules of M. charantia also depolarize the L-cell through elevation of intracellular Ca

conclusionThe findings tend to provide a possible explanation for the hypoglycemic action of M. charantia fruit extracts as alternative nutritional therapy in the management and treatment of diabetes.

Indexed as

Hypoglycemic AgentsMomordica charantiaPlant ExtractsAnimalsDiabetes Mellitus, ExperimentalGlucagon-Like Peptide 1GlycogenInsulinMaleRatsRats, WistarGlucagon-Like Peptide 1GlycogenHypoglycemic AgentsInsulinPlant ExtractsDiabetes mellitusGlucagon-like peptide 1Momordica charantiaWistar rats

Identifiers

PMID29776414
PMCPMC5960212
OpenAlexW2804010377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.